Specific Alternation of Gut Microbiota and the Role of Ruminococcus gnavus in the Development of Diabetic Nephropathy
Journal of Microbiology and Biotechnology · 28.03.2024 · 34 (3) · 547-561
DOI: 10.4014/jmb.2310.10028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, online erschienen am 26.12.2023. Verfasst von Jinni Hong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical Universi…. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Gastrointestinal Microbiome, Diabetes Mellitus. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Guangdong Provincial People's Hospital and Sun Yat-sen University.
Abstract (Originalsprache)
In this study, we aim to investigate the precise alterations in the gut microbiota during the onset and advancement of diabetic nephropathy (DN) and examine the impact of Ruminococcus gnavus (R. gnavus) on DN. Eight-week-old male KK-Ay mice were administered antibiotic cocktails for a duration of two weeks, followed by oral administration of R. gnavus for an additional eight weeks. Our study revealed significant changes in the gut microbiota during both the initiation and progression of DN. Specifically, we observed a notable increase in the abundance of Clostridia at the class level, higher levels of Lachnospirales and Oscillospirales at the order level, and a marked decrease in Clostridia_UCG-014 in DN group. Additionally, there was a significant increase in the abundance of Lachnospiraceae, Oscillospiraceae, and Ruminococcaceae at the family level. Moreover, oral administration of R. gnavus effectively aggravated kidney pathology in DN mice, accompanied by elevated levels of urea nitrogen (UN), creatinine (Cr), and urine protein. Furthermore, R. gnavus administration resulted in down-regulation of tight junction proteins such as Claudin-1, Occludin, and ZO-1, as well as increased levels of uremic toxins in urine and serum samples. Additionally, our study demonstrated that orally administered R. gnavus up-regulated the expression of inflammatory factors, including nucleotide-binding oligomerization domain-like receptor pyrin domain-containing protein 3 (NLRP3) and Interleukin (IL)-6. These changes indicated the involvement of the gut-kidney axis in DN, and R. gnavus may worsen diabetic nephropathy by affecting uremic toxin levels and promoting inflammation in DN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Traditional Chinese Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, P.R. China.
- Guangdong Provincial Institute of Geriatric, Guangzhou, 510080, P.R. China.
- Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, P.R. China.
Förderung
- Guangdong Provincial People's Hospital and Sun Yat-sen University
Zitieren
APA
Hong, J., Fu, T., Liu, W., Du, Y., Bu, J., Wei, G., Yu, M., Lin, Y., Min, C., & Lin, D. (2024). Specific Alternation of Gut Microbiota and the Role of Ruminococcus gnavus in the Development of Diabetic Nephropathy. Journal of Microbiology and Biotechnology, 34(3), 547-561. https://doi.org/10.4014/jmb.2310.10028
Vancouver
Hong J, Fu T, Liu W, Du Y, Bu J, Wei G, et al. Specific Alternation of Gut Microbiota and the Role of Ruminococcus gnavus in the Development of Diabetic Nephropathy. Journal of Microbiology and Biotechnology. 2024;34(3):547-561. doi:10.4014/jmb.2310.10028
BibTeX
@article{Hong2024,
author = {Hong, Jinni and Fu, Tingting and Liu, Weizhen and Du, Yu and Bu, Junmin and Wei, Guojian and Yu, Miao and Lin, Yanshan and Min, Cunyun and Lin, Datao},
title = {Specific Alternation of Gut Microbiota and the Role of Ruminococcus gnavus in the Development of Diabetic Nephropathy},
journal = {Journal of Microbiology and Biotechnology},
year = {2024},
volume = {34},
number = {3},
pages = {547--561},
doi = {10.4014/jmb.2310.10028}
}
EUVIMED